Ajanta Pharma Q3 Profit Up 11% to Rs 233 cr
Ajanta Pharma's consolidated profit after tax for Q3 FY25 rose 11% YoY to Rs 233 crore, driven by increased revenue. The company's shares closed 1.64% higher on BSE.
New Delhi, Jan 30 (PTI) Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11 per cent on-year to Rs 233 crore for the third quarter ended December 31, 2024.
The drug firm had reported a profit after tax (PAT) of Rs 210 crore in the October-December period of last fiscal.
Revenue from operations stood at Rs 1,146 crore in the third quarter compared to Rs 1,105 crore in the year-ago period, Ajanta Pharma said in a regulatory filing.
Shares of the company settled 1.64 per cent higher at Rs 2,670.70 apiece on the BSE.
The drug firm had reported a profit after tax (PAT) of Rs 210 crore in the October-December period of last fiscal.
Revenue from operations stood at Rs 1,146 crore in the third quarter compared to Rs 1,105 crore in the year-ago period, Ajanta Pharma said in a regulatory filing.
Shares of the company settled 1.64 per cent higher at Rs 2,670.70 apiece on the BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 8.23 (+ 1.60)
- 120450353
- Standard Capital
- 0.55 (+ 3.77)
- 26234194
- AvanceTechnologies
- 0.64 (+ 18.52)
- 15503509
- G G Engineering
- 0.97 (+ 7.78)
- 14312441
- Sharp Investments
- 1.14 (+ 20.00)
- 10870953
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback